First in Human Dermatology study

Royal Liverpool Clinical Research Unit performs first in human dermatology study ahead of schedule

The sponsor had developed a new drug as an alternative to steroid/ antibiotic treatment for patients suffering with severe eczema. The study was to begin with individuals having a single dose of the drug administered whilst in the research unit followed by dosing at home twice a day for two weeks. Eczema is a common skin condition amongst people within the North West area and the clinical resea...

More about the Human dermatology study

Vaccination study

Royal Liverpool Clinical Research Unit performs pneumonia vaccine study ahead of schedule

The sponsor had developed a new vaccine to help develop a new and better way to protect the body against a bacterium, called Streptococcus pneumonia. This vaccine is designed to prevent disease caused by all strains of pneumococcus, which is unlike other currently available vaccines that do not protect against all strains. This vaccine has been tested for safety using healthy volunteers. The p...

More about the Vaccine Trial